Cita APA

Zhao, S., Li, R., Dai, W., Yu, B., Chen, L., & Huang, X. (2017). Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway. PLoS One.

Citación estilo Chicago

Zhao, Shui-ping, Rong Li, Wen Dai, Bi-lian Yu, Lu-zhu Chen, y Xian-sheng Huang. "Xuezhikang Contributes to Greater Triglyceride Reduction Than Simvastatin in Hypertriglyceridemia Rats By Up-regulating Apolipoprotein A5 Via the PPARα Signaling Pathway." PLoS One 2017.

Cita MLA

Zhao, Shui-ping, et al. "Xuezhikang Contributes to Greater Triglyceride Reduction Than Simvastatin in Hypertriglyceridemia Rats By Up-regulating Apolipoprotein A5 Via the PPARα Signaling Pathway." PLoS One 2017.